# Insulin Aspart Protamine and Insulin Aspart Mix 70/30

NDC: 73070-200
Generic name: insulin aspart
Labeler / Manufacturer: Novo Nordisk Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: SUBCUTANEOUS
Marketing started: 20011101

FDA application: BLA021172

## Active ingredients

- INSULIN ASPART: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73070-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73070-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc94baa4-3606-48bc-a781-9617ab6960ef